Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Abbott Q2 Profit Beats Estimates; Confirms FY13 EPS Guidance

Abbott (ABT: Quote) reported that its second-quarter net earnings from continuing operations increased to $476 million or $0.30 per share, from $411 million or $0.26 per share last year. Net earnings from continuing operations excluding specified items was $724 million or $0.46 per share, compared to $689 million or $0.43 per share, last year. Net earnings for the quarter was $476 million or $0.30 per share, compared to $1.73 billion or $1.08 per share last year.

On average, 22 analysts polled by Thomson Reuters expected the company to report profit of $0.44 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales rose to $5.45 billion from $5.31 billion last year. Analysts expected revenue of $5.52 billion for the quarter.

Reported sales increased 2.5 percent, including an unfavorable 1.7 percent effect of foreign exchange. Sales were driven by 8.4 percent operational sales growth in Nutrition, including 18.4 percent international growth, and 7.6 percent operational sales growth in Diagnostics, the company said. Excluding foreign exchange, worldwide sales increased 4.2 percent.

Abbott confirmed its ongoing earnings-per-share guidance for the full year 2013 of $1.98 to $2.04. Abbott forecasts net specified items for the full year 2013 of approximately $0.59 per share. Including these net specified items, projected earnings per share from continuing operations would be $1.39 to $1.45. Analysts expect the company to report fiscal 2013 profit per share of $2.01.

Register
To receive FREE breaking news email alerts for Abbott Laboratories and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.